Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 90
Selected: 0
NCT IDTitle
NCT00770029IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2
NCT06381999Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool
NCT04210258Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face
NCT00770211IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines
NCT00936026Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane
NCT00827008Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus
NCT00983099Evaluation of Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of Neramexane Mesylate in Healthy Japanese Subjects
NCT07018713A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
NCT04792398Bruxism Xeomin® Intervention Trial
NCT02462317Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
NCT01900041A Study to Evaluate the Superiority, Efficacy and Tolerability of Combination Pantovigar With 2% Minoxidil vs 2% Minoxidil in Women With Female Pattern Hair Loss
NCT03256942Evaluation of the Sensitivity of Merz Lips Fullness Assessment Scale Following Etermis 4® Treatment for Lips Volume Augmentation
NCT04177212Investigation of the Effectiveness and Safety of MRZF111 in the Treatment of Décolleté Wrinkles
NCT07018700A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
NCT00955799Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus
NCT06995287Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Severe Primary Dysmenorrhea
NCT03119948Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis
NCT00465738IncobotulinumtoxinA (Xeomin) for Upper Limb Spasticity
NCT04766723A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm
NCT01893411Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Leg(s) in Cerebral Palsy
NCT04075981Prevention Atrial Fibrillation by BOTulinum Toxin Injections (BOTAF)
NCT03806933Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines
NCT02207946Botulinum Toxin A to Treat Arm Tremor
NCT01405482Botulinum Toxin Injections for Thoracic Outlet Syndrome
NCT01910896Effectiveness and Safety Study of Overnight Intensive Patch in Scars
NCT00515944Evaluate the Migration Potential of Xeomin® Compared to Two Other Botulinum Toxin Type A Products
NCT00406367IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm
NCT00772980Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus
NCT05884528Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia
NCT00507637Blepharospasm Short Interval
NCT00972127Changes in the Renal Excretion of Neramexane by Acidification of Urinary pH Study With and Without Application of a Urinary pH Acidification Regimen
NCT00661440Efficacy and Safety Study of Neramexane to Treat Congenital and Acquired Nystagmus
NCT05623111Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower Extremities
NCT00694148Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines
NCT02577224An RCT of a Patient-initiated Treatment Service for BEB and HFS
NCT01999894Open-label Study of Safety and Tolerability of Memantine in Children With Autism
NCT01905683Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
NCT00777803NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
NCT00624026Memantine - Communication Study
NCT00649220Memantine and Antipsychotics Use
NCT00804271Memantine and Validation of a New Alzheimer's Disease Scale
NCT01515371Dose Finding Study for a Botulinum Toxin Type A Injection to Treat Habitual Snoring
NCT02188277Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy
NCT00405886Neramexane for Tinnitus
NCT01392300Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
NCT01486264Open-Label Non-Inferiority Study Evaluating the Efficacy and Safety of Xeomin® in Subjects With Cervical Dystonia Flex
NCT02270736Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
NCT01565395Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)
NCT01109680A Single Center, Open-Label Study to Quantify Metabolites of [14C]-Neramexane in Plasma and Urine in Healthy Male Subjects
NCT03986424Local Study of Akatinol Memantine in VaD in Russia